Potential prognostic value of leptin receptor in hepatocellular carcinoma

Journal of Clinical Pathology

Volumn 59, Issue 12, 2006, Pages 1267-1271

  Wang, S N ^a   Chuang, S C ^a   Yeh, Y T ^b   Yang, S F ^a   Chai, C Y ^a   Chen, W T ^a   Kuo, K K ^a   Chen, J S ^a   Lee, K T ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD31 ANTIGEN; LEPTIN RECEPTOR; MONOCLONAL ANTIBODY KI 67;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD31; CARCINOMA, HEPATOCELLULAR; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; RECEPTORS, CELL SURFACE; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 33845655434     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.033464     Document Type: Article

References (30)

1. Moller H, Mellemgaard A, Lindvig K, et al. Obesity and cancer risk: a Danish record-linkage study. Eur J Cancer 1994;30:344-50.
2. Chow WH, Blot WJ, Vaughan TL, et al. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 1998;90:150-5.
3. Peto J. Cancer epidemiology in the last century and the next decade. Nature 2001;411:390-5.
4. Bergstrom A, Hsieh CC, Lindblad P, et al. Obesity and renal cell cancer-a quantitative review. Br J Cancer 2001;85:984-90.
5. Noir S, Mason A, Eason J, et al. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 2002;36:150-5.
6. Calle EE, Rodriguez C, Walker-Thurmond K, et al. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
7. Caldwell SH, Crespo DM, Kang HS, et al. Obesity and hepatocellular carcinoma. Gastroenterology 2004;127:S97-103.
8. Freeman HJ. Risk of gastrointestinal malignancies and mechanisms of cancer development with obesity and its treatment. Best Pract Res Clin Gastroenterol 2004;18:1167-75.
9. Wang YY, Lin SY. Leptin in relation to hepatocellular carcinoma in patients with liver cirrhosis. Horm Res 2003;60:185-90.
10. Liu ZW, Zhang N, Han QY, et al. Correlation of serum leptin levels with anthropometric and metabolic parameters and biochemical liver function in Chinese patients with chronic hepatitis C virus infection. World J Gastroenterol 2005;11:3357-62.
11. Scharf MT, Ahima RS. Gut peptides and other regulators in obesity. Semin Liver Dis 2004;24:335-47.
12. Malik KF, Young WS. 3rd Localization of binding sites in the central nervous system for leptin (OB protein) in normal, obese (ob/ob), and diabetic (db/db) C57BL/6J mice. Endocrinology 1996;137:1497-500.
13. Smith-Kirwin SM, O'Connor DM, De Johnston J, et al. Leptin expression in human mammary epithelial cells and breast milk. J Clin Endocrinol Metab 1998;83:1810-3.
14. Glasow A, Haidan A, Hilbers U, et al. Expression of Ob receptor in normal human adrenals: differential regulation of adrenocortical and adrenomedullary function by leptin. J Clin Endocrinol Metab 1998;83:4459-66.
15. Briscoe CP, Hanif S, Arch JR, et al. Leptin receptor long-form signaling in a human liver cell line. Cytokine 2001;14:225-9.
16. Sobhani I, Bado A, Vissuzaine C, et al. Leptin secretion and leptin receptor in the human stomach. Gut 2000;47:178-83.
17. Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004;10:4325-31.
18. Tsuchiya T, Shimizu H, Hori T, et al. Expression of leptin receptor in lung: leptin as a growth factor. Eur J Pharmacol 1999;365:273-9.
19. Mix H, Widjaja A, Jandl O, et al. Expression of leptin receptor isoforms in the human stomach. Gut 2000;47:481-6.
20. Hino M, Nakano T, Yamane T, et al. Leptin receptor and leukemia. Leuk Lymphoma 2000;36:457-61.
21. Wang XJ, Yuan SL, Lu Q, et al. Potential involvement of leptin in carcinogenesis of hepatocellular carcinoma. World J Gastroenterol 2004;10:2478-81.
22. Rose DP, Gilhooly EM, Nixon DW. Adverse effects of obesity on breast cancer prognosis, and the biological actions of leptin (review). Int J Oncol 2002;21:1285-92.
23. Aparicio T, Kotelevets L, Tsocas A, et al. Leptin stimulates the proliferation of human colon cancer cells in vitro but does not promote the growth of colon cancer xenografts in nude mice nor intestinal tumourigenesis in ApcMin/+ mice. Gut 2005;54:1136-45.
24. The Liver Cancer Study Group of Japan. The general rules for clinical and pathological study of primary liver cancer. 3rd edn. Tokyo: Kanehara Co Ltd, 1992.
25. Bado A, Levasseur S, Attoub S, et al. The stomach is a source of leptin. Nature 1998;394:790-3.
26. Weidner N. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol 1995;147:9-19.
27. Frachon S, Gouysse G, Dumortier J, et al. Endothelial cell marker expression in dysplastic lesions of the liver: an immunohistochemical study. J Hepatol 2001;34:850-7.
28. Park YN, Kim YB, Yang KM, et al. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogenesis. Arch Pathol Lab Med 2000;124:1061- 5.
29. Yao DF, Wu XH, Zhu Y, et al. Quantitative analysis of vascular endothelial growth factor, microvascular density and their clinicopathologic features in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 2005;4:220-6.
30. Deli G, Jin CH, Mu R, et al. Immunohistochemical assessment of angiogenesis in hepatocellular carcinoma and surrounding cirrhotic liver tissues. World J Gastroenterol 2005;11:960-3.